4 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 10 points (0.1%) at 14,085 as of Thursday, Feb. 28, 2013, 12:04 PM ET. The NYSE advances/declines ratio sits at 1,607 issues advancing vs. 1,243 declining with 160 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was Fresenius Medical Care Corporation ( FMS), up 0.8%. A company within the industry that increased today was DaVita HealthCare Partners ( DVA), up 1.4%.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today:

4. Cigna ( CI) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $0.26 (-0.4%) to $58.72 on light volume Thus far, 601,373 shares of Cigna exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $58.18-$59.03 after having opened the day at $58.92 as compared to the previous trading day's close of $58.98.

CIGNA Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $16.5 billion and is part of the health care sector. The company has a P/E ratio of 9.7, below the S&P 500 P/E ratio of 17.7. Shares are up 10.3% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Cigna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, attractive valuation levels, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cigna Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Healthcare Management Stocks Look Too Pricey for Activists

The Stock That Crashed 25% Overnight Has a Lesson to Teach Us: Market Recon